MedTrace Logo

The Platinum Study Comparison Group

NCT02890030 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2020-04-08

No results posted yet for this study

Summary

The patients enrolled on this new study will serve as an appropriate comparison group consisting of patients with the diagnosis of germ cell testicular cancer who were cured with surgical resection and did not receive cisplatin-based chemotherapy with a group of patients from another study who did receive cisplatin-based chemotherapy.

Conditions

  • Testicular Neoplasms

Interventions

BEHAVIORAL

Questionnaire

* Neurotoxicity * Medications of interest * General health * Family history

Sponsors & Collaborators

  • Lawrence Einhorn

    lead OTHER

Principal Investigators

  • Lawrence Einhorn, MD · Indiana University School of Medicine, Indiana University Simon Cancer Center

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-06-14
Completion
2017-06-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02890030 on ClinicalTrials.gov